---
title: Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression
  in Adult T-cell leukemia/lymphoma
date: '2023-12-24'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38142436/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20231225170640&v=2.18.0
source: Blood
description: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive T-cell malignancy
  with a poor prognosis and limited treatment options. Programmed cell death ligand
  1(PD-L1) is recognized to be involved in the pathobiology of ATLL. However, what
  molecules control PD-L1 expression and whether genetic or pharmacological intervention
  might modify PD-L1 expression in ATLL cells is still unknown. In order to comprehend
  the regulatory mechanisms of PD-L1 expression in ATLL cells, we performed ...
disable_comments: true
---
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive T-cell malignancy with a poor prognosis and limited treatment options. Programmed cell death ligand 1(PD-L1) is recognized to be involved in the pathobiology of ATLL. However, what molecules control PD-L1 expression and whether genetic or pharmacological intervention might modify PD-L1 expression in ATLL cells is still unknown. In order to comprehend the regulatory mechanisms of PD-L1 expression in ATLL cells, we performed ...